Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein.
British journal of clinical pharmacology • Vol. 88, Issue 9 • 2022
Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile.
Journal of neuroendocrinology • Vol. 24, Issue 1 • 2012
Translocator protein as a promising target for novel anxiolytics.
Current topics in medicinal chemistry • Vol. 12, Issue 4 • 2012
Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold.
Journal of medicinal chemistry • Vol. 54, Issue 20 • 2011